The Canadian Clinical Trials Asset Map (CCTAM) is recommendation #9 of the action plan. The CCTAM is a unique, robust, searchable web-based database designed to communicate Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors.
The CCTAM software is currently under development and Phase I of data collection is underway.
The purposes of this pan-Canadian initiative are to:
- Showcase the tremendous assets we have in Canada to conduct clinical trials
- Better enable sponsors of clinical trials to identify clinical research sites and investigators
- Become a comprehensive database for all Canadian clinical research assets; the essential tool for anyone planning on conducting clinical research in Canada
- Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace
Some of CCTAM’s many features include:
- Regular updates
- Easy to search
- Comprehensive data set